Bausch Health Companies Inc. (BHC)
BHC moved a median of +0.06% 30 minutes after news, and -0.06% by the close. How BHC actually reacts to news — the realized, point-in-time move the market made, measured across 412 labeled events over the last three years with zero look-ahead.
BHC’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.01% | 51% | 410 |
| 30-min | +0.06% | 50% | 411 |
| 60-min | -0.08% | 47% | 411 |
| to close | -0.06% | 48% | 408 |
| Middle 50% of BHC reactions | -0.75% to +1.24% |
|---|---|
| Median reaction (30-min) | +0.06% |
| Measured reactions | 412 |
Half of all Bausch Health Companies Inc. news events land between -0.75% and +1.24% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How BHC reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 21 | -0.31% | 38% | -0.61% |
| Analyst downgrades | 17 | +0.48% | 71% | -0.24% |
| Rating reiterations | 16 | +0.09% | 56% | +0.39% |
| Price-target cuts | 10 | -0.06% | 50% | -0.37% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how BHC ranks against every other measured name →
That’s how BHC usually reacts — get an email when it moves on news →Email me when BHC moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BHC's baseline. Nothing else.
Recent BHC events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway | Press release | Canada Newswire | +3.78% | -2.47% | |
| Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026 | Press release | Canada Newswire | -0.08% | +1.35% | |
| (Pr)SILIQ® (brodalumab injection) Now Reimbursed Under Alberta's Public Drug Plan, Improving Access for Eligible Patients with Moderate to Severe Plaque Psoriasis | Press release | Canada Newswire | -0.15% | -2.13% | |
| Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets | Press release | Canada Newswire | -0.15% | -2.13% | |
| Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia | Press release | PR Newswire | +0.78% | +1.25% | |
| Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia | Press release | PR Newswire | +0.78% | +1.25% | |
| Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners | Press release | PR Newswire | -0.93% | -2.63% | |
| Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners | Press release | PR Newswire | +0.86% | +2.97% | |
| Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board | Press release | PR Newswire | -2.81% | -6.93% | |
| Form 10-Q Bausch Health Companies For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +2.31% | +13.70% | |
| BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE | Press release | Canada Newswire | +9.20% | +20.60% | |
| Form 8-K Bausch Health Companies For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +9.20% | +20.60% | |
| (Pr)ELIDEL® (pimecrolimus) cream Now Reimbursed Under Alberta's Public Drug Plan for Eligible Patients with Mild to Moderate Atopic Dermatitis | Press release | Canada Newswire | +0.66% | -1.09% | |
| Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 | Press release | Canada Newswire | +1.23% | +0.82% | |
| Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia | Press release | Canada Newswire | -0.82% | -1.23% | |
| Form 8-K Bausch Health Companies For: Jun 26 | SEC filing · Form 8-K | SEC EDGAR | -1.44% | +1.03% | |
| Michael Goettler Resigns from Bausch Health's Board of Directors | Press release | Canada Newswire | -1.44% | +1.03% | |
| Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia | Press release | Canada Newswire | +0.39% | +0.00% | |
| Form SD Bausch Health Companies | SEC filing · Form SD | SEC EDGAR | -0.19% | -4.75% | |
| Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China | Press release | PR Newswire | +0.00% | -0.56% | |
| Bausch Health Announces 2026 Annual Meeting of Shareholder Results | Press release | PR Newswire | -0.75% | +3.58% | |
| Form 8-K Bausch Health Companies For: May 19 | SEC filing · Form 8-K | SEC EDGAR | -0.75% | +3.58% | |
| Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference | Press release | Canada Newswire | -1.11% | -1.85% | |
| Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference | Press release | Canada Newswire | -1.11% | -1.85% | |
| Form 10-Q Bausch Health Companies For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.80% | -3.05% | |
| BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS | Press release | Canada Newswire | +2.80% | -3.05% | |
| Form 8-K Bausch Health Companies For: Apr 29 | SEC filing · Form 8-K | SEC EDGAR | +2.80% | -3.05% | |
| Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering | Press release | PR Newswire | +1.04% | -1.39% | |
| Form ARS Bausch Health Companies For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.00% | +1.51% | |
| Form DEF 14A Bausch Health Companies For: May 19 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +1.51% | |
| Form DEFA14A Bausch Health Companies | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +1.51% | |
| Bausch Health to Announce First Quarter 2026 Results on April 29, 2026 | Press release | PR Newswire | +1.18% | +5.88% | |
| Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program | Press release | PR Newswire | +1.60% | +2.20% | |
| Form 8-K Bausch Health Companies For: Feb 26 | SEC filing · Form 8-K | SEC EDGAR | +0.69% | -0.69% | |
| Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada | Press release | PR Newswire | +1.80% | -1.97% | |
| Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres | Press release | PR Newswire | -0.71% | +4.96% | |
| Form 10-K Bausch Health Companies For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.71% | +4.96% | |
| BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS | Press release | PR Newswire | -0.71% | +4.96% | |
| Form 8-K Bausch Health Companies For: Feb 18 | SEC filing · Form 8-K | SEC EDGAR | -0.71% | +4.96% | |
| Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference | Press release | PR Newswire | +0.58% | -0.99% | |
| Bausch Health Announces 2026 Gastrointestinal Health Scholars Program | Press release | PR Newswire | -0.33% | -0.49% | |
| Bausch Health Provides Update on RED-C Phase 3 Clinical Trials | Press release | PR Newswire | -0.16% | -4.68% | |
| Form 8-K Bausch Health Companies For: Jan 23 | SEC filing · Form 8-K | SEC EDGAR | -0.51% | -1.19% | |
| Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026 | Press release | PR Newswire | -0.73% | -2.92% | |
| Form 8-K Bausch Health Companies For: Jan 13 | SEC filing · Form 8-K | SEC EDGAR | -1.53% | -0.40% | |
| Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference | Press release | PR Newswire | +2.69% | +2.07% | |
| Form 8-K Bausch Health Companies For: Jan 02 | SEC filing · Form 8-K | SEC EDGAR | +2.69% | +2.07% | |
| Form 8-K Bausch Health Companies For: Dec 26 | SEC filing · Form 8-K | SEC EDGAR | +0.28% | -0.70% | |
| Bausch Health Announces Final Results and Expiration of Exchange Offers | Press release | ACCESS Newswire | -1.16% | -2.18% | |
| Form 8-K Bausch Health Companies For: Dec 23 | SEC filing · Form 8-K | SEC EDGAR | -1.16% | -2.18% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BHC section they belong to.
Where else BHC is measured.
BHC earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| VITAL THERAPIES (VTL) | 415 | -0.05% | 44% |
| Zai Lab Limited - American Depositary Shares (ZLAB) | 415 | 0.00% | 49% |
| Verastem, Inc. (VSTM) | 411 | -0.09% | 48% |
| Alphatec Holdings, Inc. (ATEC) | 409 | -0.18% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Bausch Health Companies Inc.'s median reaction calculated?
Every labeled BHC news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 412 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 50% of BHC's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BHC's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.